Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - trimethoprim, quantity: 300 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; povidone; sodium starch glycollate; purified talc; magnesium stearate - this product approved for registration as a variation of a product accepted for inclusion in the artg as 'currently supplied' at the commencement of the act. indications are held in artg paper records. previous product number aust r 17577 and 43120. product information not reviewed. indications as at 5 december 1984 : treatment of acute urinary tract infections caused by sensitive organisms.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

randlab australia pty ltd - trimethoprim - unknown - trimethoprim pyrimidine active 0.0 - active constituent

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ccd animal health pty ltd - trimethoprim - unknown - trimethoprim pyrimidine active 0.0 - active constituent

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

United States - English - NLM (National Library of Medicine)

avpak - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

Malta - English - Medicines Authority

p & d pharmaceuticals limited - trimethoprim - tablet - trimethoprim 100 milligram(s) - antibacterials for systemic use

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. trimethoprim sulfate and polymyxin b sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra regulatory b.v. - sulfadiazine 15 g; trimethoprim 3 g - oral paste - 333 mg/g - 67 mg/g - trimethoprim 66.7 mg/g; sulfadiazine 333.3 mg/g - sulfadiazine and trimethoprim - horse

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

kela laboratoria - trimethoprim 50 mg/g; sulfadiazine 250 mg/g - oral powder - 250 mg/g; 50 mg/g - sulfadiazine sodium; trimethoprim 50 mg/g - sulfadiazine and trimethoprim - pig; cattle